| Applications | ELISA |
|---|
| Detection Method | Colorimetric |
|---|
| Sensitivity | 0.156 μg/ml |
|---|
| Detection Range | 0.31-5 μg/mL |
|---|
| Recovery | 80-120% |
|---|
| Sample Type | Plasma, Serum |
|---|
| Assay Type | Quantitative |
|---|
| Stability and Storage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
|---|
| Shipping Condition | 2-8 ℃ |
|---|
| Accession Number | P16471 |
|---|
| Background | Rituximab is a genetically engineered chimeric murine/human monoclonal antibody specific to CD20. CD20 is an approximately 35 KDa transmembrane phosphoprotein involved in the activation, proliferation, and differentiation of B-lymphocytes. It is absent in terminally differentiated plasma cells. The Fab domain of Rituximab binds to the CD20 antigen on B-lymphocytes and the Fc domain recruits immune effector functions to induce apoptosis in B cells and is used in the treatment of leukemia s and lymphomas, some autoimmune disorders, and organ transplant. |
|---|
| Alternative Names | PR-1594804, h16f, ABBV-176, DC-1630993, h16f, Rolinsatamab talirine, 2095467-30-2 |
|---|
| Note | For Research Use Only. |
|---|